BioMaTek ApS: Financial statements 2020
CVR: 38928864
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
BioMaTek ApS (CVR 38928864) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 367,673 and a net result of DKK 48,493 compared with DKK -13,126 the year before. That is an increase of 625.1% compared with the year before. Equity in the 2020 report amounted to DKK 187,510. The solvency ratio was 8.6%.
- Gross Profit
- DKK 367,673
- Profit/Loss
- DKK 48,493
- Equity
- DKK 187,510
- Total Assets
- DKK 2,178,755
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 368 t. | 48 t. | 188 t. | - |
| 2019 | - | 51 t. | -13 t. | 139 t. | - |
Official annual report
How creditworthy is BioMaTek ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BioMaTek ApS
BioMaTek ApS is a Danish company of the type Anpartsselskab based in Bedsted Thy, founded in 2017. The company is in liquidation. The company is registered under the industry Installation af isolering. The management consists of Jacob Morten Schousgaard. The company is owned by K.Y.M. ApS, TVT Group ApS and HN2024 Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 305,673 and a net result of DKK 6,138. Equity in the 2025 report amounted to DKK 18,905.